Search results for "Insulin"

showing 10 items of 1360 documents

NephroCheck: should we consider urine osmolality?

2019

medicine.medical_specialtyLetterCritical Care030232 urology & nephrologyMEDLINEUrine030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineAcute Kidney Injury; Biomarkers Humans Insulin-Like Growth Factor Binding Proteins Research Design Tissue Inhibitor of Metalloproteinase-2 Urine Osmolar ConcentrationOsmolar Concentration03 medical and health sciences0302 clinical medicinemedicineHumansTissue Inhibitor of Metalloproteinase-2Intensive Care Medicinebusiness.industryOsmolar Concentrationlcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Acute Kidney InjuryInsulin-Like Growth Factor Binding ProteinsResearch DesignEmergency medicineUrine osmolalitybusinessBiomarkersCritical Care
researchProduct

Non-alcoholic fatty liver disease pathogenesis: The present and the future

2008

Non-alcoholic fatty liver disease is the clinical hepatic expression of metabolic syndrome. The prevalence of non-alcoholic fatty liver disease is around 20-30%, and with a rapid increase in the metabolic risk factors in the general population, non-alcoholic fatty liver disease has become the most common cause of liver disease worldwide. A fraction (20-30%) of non-alcoholic fatty liver disease patients develop a potentially progressive hepatic disorder, namely non-alcoholic steatohepatitis, leading to end-stage liver disease. The pathogenesis of non-alcoholic fatty liver disease is not entirely understood, and even if insulin resistance is a major pathogenetic key, many other factors are im…

medicine.medical_specialtyLipolysisPopulationPhysiologyApoptosisMitochondria LiverInsulin resistance Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis SteatosisDiseaseFatty Acids NonesterifiedPathogenesisLiver diseaseInsulin resistanceAdipokinesRisk FactorsInternal medicinemedicineAnimalsHumansGenetic Predisposition to Diseaseeducationeducation.field_of_studyHepatologybusiness.industryFatty liverGastroenterologymedicine.diseaseDietFatty LiverOxidative StressEndocrinologyAdipose TissueLiverDisease ProgressionHepatocytesCytokinesInsulin ResistanceSteatohepatitisMetabolic syndromebusinessDigestive and Liver Disease
researchProduct

Adipokines and Lipoproteins: Modulation by Antihyperglycemic and Hypolipidemic Agents

2014

Abstract Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs …

medicine.medical_specialtyLipoproteinsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAdipokineAdipose tissueIncretinsNiacinAnti-Obesity AgentsInsulin resistanceAdipokinesInternal medicineInternal MedicineAnimalsHumansHypoglycemic AgentsInsulinMedicineHypolipidemic AgentsMetabolic Syndromebusiness.industryInsulinFibric AcidsEzetimibemedicine.diseaseLipidsMetforminGlucoseEndocrinologyAdipose TissueHypolipidemic AgentsAzetidinesThiazolidinedionesAnti-Obesity AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistanceMetabolic syndromebusinessHormoneMetabolic Syndrome and Related Disorders
researchProduct

Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.

2004

Type 2 diabetes is an important cardiovascular risk factor. A significant component of the risk associated with type 2 diabetes is thought to be because of its characteristic lipid "triad" profile of raised small dense low-density lipoprotein levels, lowered high-density lipoprotein, and elevated triglycerides (TGs). Trials of statins and fibrates have included substantial numbers of patients with diabetes and indicate that lipid lowering reduces cardiovascular event rates in these patients. However, statins alone do not always address all the lipid abnormalities of diabetes. Fibrates, which have low affinity for peroxisome proliferator-activated receptor alpha (PPARalpha), improve most asp…

medicine.medical_specialtyLipoproteinsPeroxisome proliferator-activated receptorType 2 diabetesInsulin resistanceRisk FactorsInternal medicineDiabetes mellitusmedicineLipolysisHumansPPAR alphaDyslipidemiaschemistry.chemical_classificationbusiness.industrynutritional and metabolic diseasesLipid metabolismmedicine.diseaseLipid MetabolismEndocrinologychemistryDiabetes Mellitus Type 2Cardiovascular Diseaseslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessDyslipidemiaLipoproteinAmerican heart journal
researchProduct

Postnatal Overfeeding in Rodents by Litter Size Reduction Induces Major Short- and Long-Term Pathophysiological Consequences

2013

Numerous studies have demonstrated that the early postnatal environment can influence body weight and energy homeostasis into adulthood. Rodents raised in small litters have been shown to be a useful experimental model to study the short- and long-term consequences of early overnutrition, which can lead to modifications not only in body weight but also of several metabolic features. Postnatal overfeeding (PNOF) induces early malprogramming of the hypothalamic system, inducing acquired persisting central leptin and insulin resistance and an increase in orexigenic signals. Visceral white adipose tissue, lipogenic activity, and inflammatory status are increased in PNOF rodents, while brown adi…

medicine.medical_specialtyLitter Sizemedia_common.quotation_subjectHypothalamusAppetiteMedicine (miscellaneous)White adipose tissueHyperphagiaBiologyEnergy homeostasisToxicology03 medical and health scienceschemistry.chemical_compoundOvernutrition0302 clinical medicineInsulin resistanceCorticosteroneInternal medicineBrown adipose tissuemedicineAnimalsHumansHormone metabolismObesityInfant Nutritional Physiological Phenomena030304 developmental biologymedia_common2. Zero hunger0303 health sciencesNutrition and DieteticsLeptinInfantAppetitemedicine.diseaseHormonesEndocrinologymedicine.anatomical_structureAdipose TissuechemistryCardiovascular DiseasesInsulin ResistanceEnergy Intake030217 neurology & neurosurgeryThe Journal of Nutrition
researchProduct

The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells

1997

Oval cells are small nonparenchymal epithelial cells that first appear in the periportal areas of the liver and thereafter invade the whole parenchyma when mice or rats are exposed to a variety of chemical carcinogens. In the present study we have analyzed the expression of insulin-like growth factor II (IGF II) in the recently established oval cell line OC/CDE 22 and its malignantly transformed counterpart (the M22 cells) and the biological consequences of the constitutive expression of IGF II in oval cells. OC/CDE 22 cells do not express the above-mentioned growth factor, whereas the M22 cells do and addition of a neutralizing anti-IGF II antibody to M22 cells resulted in an almost comple…

medicine.medical_specialtyLiver cytologymedicine.medical_treatmentBiologyCell LineMalignant transformationMiceLiver Neoplasms ExperimentalGrowth factor receptorInsulin-Like Growth Factor IINeutralization TestsInternal medicinemedicineAnimalsAutocrine signallingHepatologyGrowth factorEpithelial CellsOncogenesTransfectionMolecular biologyRatsCell Transformation NeoplasticEndocrinologyLiverCell cultureInsulin-like growth factor 2biology.proteinMitogensHepatology
researchProduct

Association between Periodontal Diseases and Polycystic Ovary Syndrome: A Systematic Review

2020

Background: A convergent association between polycystic ovary syndrome (PCOS) and periodontal disease, in particular chronic periodontitis (CP), has recently been proposed. The underlying molecular mechanisms of this association are not fully understood, though it is thought that chronic inflammation is responsible. Therefore, the aim of this study was to evaluate the association between periodontal disease—gingivitis and CP—and PCOS. Materials and Methods: The PICO (Participants, Intervention, Control, and Outcomes) question was as follows: “Is there an association between PCOS and CP?” A systematic review of three databases—PubMed, Embase and Scopus—was performed following PRISMA (Preferr…

medicine.medical_specialtyMEDLINElcsh:MedicineReview03 medical and health sciences0302 clinical medicineInsulin resistancePeriodontal diseaseInternal medicineinsulin resistanceMedicineIn patientAssociation (psychology)030304 developmental biology0303 health sciencesbusiness.industrylcsh:Rchronic periodontitis030206 dentistryGeneral Medicinemedicine.diseaseChronic periodontitisPolycystic ovarySystematic reviewpolycystic ovary syndromebusinessperiodontal diseasesJournal of Clinical Medicine
researchProduct

Magnesium metabolism in hypertension and type 2 diabetes mellitus.

2007

The increasing evidence for the clinical relevance of altered magnesium metabolism to states of altered insulin resistance confirms the role of magnesium deficit as a possible underlying common mechanism of the "insulin resistance" of hypertension and altered glucose tolerance. The pioneer work of Lawrence M. Resnick and his group using the cellular ion-based approach that we are only partially presenting here has consistently contributed to the progress of the field, demonstrating (a) the critical importance of magnesium metabolism in regulating insulin sensitivity as well as vascular tone, and blood-pressure homeostasis; (b) that magnesium deficiency, defined on the basis of intracellular…

medicine.medical_specialtyMagnetic Resonance Spectroscopychemistry.chemical_elementEssential hypertensionInsulin resistancePre-EclampsiaPregnancyMagnesium deficiency (medicine)Diabetes mellitusInternal medicinemedicineHumansPharmacology (medical)MagnesiumSodium Chloride DietaryPharmacologyCalcium metabolismMagnesiumbusiness.industryType 2 Diabetes MellitusGeneral MedicineSyndromemedicine.diseaseEndocrinologychemistryDiabetes Mellitus Type 2HypertensionCalciumFemaleInsulin ResistancebusinessMagnesium DeficiencyHomeostasisAmerican journal of therapeutics
researchProduct

The Ionic Hypothesis of Aging

1998

The clinical association of essential hypertension with metabolic abnormalities, such as hyperinsulinemia, insulin resistance, obesity, altered glucose tolerance and/or frank non-insulin dependent diabetes mellitus (NIDDM) has long been appreciated(1). Each of the above clinical conditions is extremely frequent in the elderly. The association of these different clinical states, that is also common at younger ages, has been termed “Syndrome X” and more recently “Generalized Cardiovascular-Metabolic Disease.”(2,3) Although several hypothesis have been proposed, including a primary role of hyperinsulinemia and insulin resistance, the mechanism(s) of this linkage has not been established. This …

medicine.medical_specialtyMechanism (biology)business.industrymedicine.diseaseLeft ventricular hypertrophyEssential hypertensionObesitychemistry.chemical_compoundInsulin resistanceEndocrinologyDehydroepiandrosterone sulfatechemistryInternal medicineDiabetes mellitusmedicineHyperinsulinemiabusiness
researchProduct

Comprehensive pharmacokinetic model of insulin Glargine and other insulin formulations.

2005

In this paper, a comprehensive pharmacokinetic model for different insulin formulations including insulin Glargine is developed based on the model proposed by Trajanoski et al. (1993). Current models show limitations for insulin Glargine due to the appearance of an uncharacteristic peak in the concentration-time evolution of plasma insulin that does not coincide with real experimental data. This important limitation has been solved in this paper by introducing a new virtual insulin state called the bound state, in addition to the dimeric and hexameric ones. Trying to describe the retarded action of insulin Glargine, the modeling idea behind this approach is that immediately after the subcut…

medicine.medical_specialtyMetabolic Clearance Ratemedicine.medical_treatmentBiomedical EngineeringInsulin GlargineModels BiologicalInsulin Infusion SystemsPharmacokineticsInternal medicinemedicineApplied mathematicsHumansInsulinComputer SimulationSpatial diffusionMathematicsInsulin glargineInsulinDrug Therapy Computer-AssistedInsulin Long-ActingExogenous insulinEndocrinologyLiverPatient behaviorPlasma insulinmedicine.drugIEEE transactions on bio-medical engineering
researchProduct